Esther Martinborough
Director/Board Member at CODEXIS, INC.
Net worth: 153 522 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Marcus F. Boehm | M | 64 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 7 years |
Stephen Dilly | M | 64 | 4 years | |
Margaret Fitzgerald | F | 53 | 2 years | |
Byron Dorgan | M | 81 | 13 years | |
Kathleen Glaub | F | 70 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 6 years |
Robert Sato | M | - | 17 years | |
Sriram Ryali | M | 43 | 1 years | |
Jennifer Aaker | M | 57 | 4 years | |
Alison Moore | M | 57 | 4 years | |
Rahul Singhvi | M | 59 | 2 years | |
David Smith | M | 64 | 8 years | |
Christian Weyer | M | 55 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 3 years |
Joshua Grass | M | - |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 3 years |
Dennis Wolf | M | 71 | 17 years | |
H. Parker | F | 68 | 2 years | |
Raidy Kevin J. | M | 55 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 4 years |
K. Hirth | M | 72 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 5 years |
Jeenjoo Kang | M | 40 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | - |
Laurie Heilmann | F | 68 | 5 years | |
Stefan Lutz | M | - | 4 years | |
Kevin Norrett | M | 51 | 2 years | |
Karen Frechou-Armijo | F | - | 3 years | |
Gregg Timony | M | - |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | - |
Lauren Rose Musto | F | - | 1 years | |
Jason Hafler | M | 42 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bernard J. Kelley | M | 82 | 17 years | |
John Nicols | M | 60 | 11 years | |
Faheem Hasnain | M | 65 | 5 years | |
Graham Cooper | M | 54 | 2 years | |
William Rastetter | M | 75 | 6 years | |
Alain D. Baron | M | 70 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | - |
Robert Peach | M | 68 | 6 years | |
Kristina Burow | F | 50 | 7 years | |
David Hinkle | M | - | - | |
Karl A. Schoene | M | - | 3 years | |
Christian Waage | M | 57 | - | |
Hugh Rosen | M | 65 | - | |
Raymond Stevens | M | 60 | - | |
Richard Heyman | M | 66 | 1 years | |
Ross Taylor | M | 60 | 4 years | |
Erle T. Mast | M | 61 | 2 years | |
James R. Schmidt | M | 63 | - | |
Douglas Cole | M | 63 | 5 years | |
Patrick Yang | M | 75 | 9 years | |
Mary Szela | F | 60 | 1 years | |
Mary Lynne Hedley | M | 61 | 1 years | |
Amir Nashat | M | 51 | 2 years | |
S. Torres | M | 61 | 6 years | |
Chrysa Mineo | F | 59 | 6 years | |
Maria Bedoya-Toro Munera | M | 72 | 1 years | |
Edwards Roberts | M | - | - | |
Sheila Gujrathi | M | 53 | 4 years | |
Justin Chakma | M | 35 | - | |
Keith Lenden | M | - | - | |
Richard Aranda | M | 64 | 3 years | |
Annette Matthies | M | 47 | 3 years | |
Asli Aras | M | - | 2 years | |
Rob Wilson | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 58 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Esther Martinborough
- Personal Network